Skip to content

Effect of laparoscopic His angle reconstruction for gastroesophageal reflux disease with hiatal hernia

Effect of laparoscopic His angle reconstruction for gastroesophageal reflux disease with hiatal hernia

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000035225
Enrollment
Unknown
Registered
2020-08-04
Start date
2012-01-02
Completion date
Unknown
Last updated
2020-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastroesophageal reflux disease with hiatal hernia

Interventions

Case series:Nil

Sponsors

The First Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 95 Years

Inclusion criteria

Inclusion criteria: Between January 2012 and July 2020, GERD patients with HH (aged =18 years old) who underwent laparoscopic HH repair combined with different antireflux operations in the Department of Intervention of First Affiliated Hospital of Zhengzhou University were recruited. GERD with HH was diagnosed according to the Guidelines for the diagnosis and management of gastroesophageal reflux disease"[1-2] and HH diagnosis criteria[8-9]. Indications for the operation were as follows: ineffective medical treatment (uncontrollable severe reflux or intolerable side effects of antacids), serious esophagitis, esophageal stenosis, Barrett's esophagus, and external symptoms (such as reflux-related asthma, reflux-related cough, reflux-related pneumonia, and reflux-related sleep disorder) seriously affecting the quality of life and requiring surgery.

Exclusion criteria

Exclusion criteria: Patients with gastroptosis, superior mesenteric artery compression syndrome, achalasia, achalasia Heller myotomy, other operations of the esophagus or stomach, severe cardiovascular and cerebrovascular diseases, respiratory system diseases, liver and kidney dysfunction, blood system diseases, malignant tumors, and/or other intolerable conditions. In addition, pregnant women and patients with mental disorders.

Design outcomes

Primary

MeasureTime frame
The operative time; intraoperative blood loss; postoperative hospital stay; postoperative 1.5-year or three-year efficacy; and within 3-year readmission and postoperative complications;

Countries

China

Contacts

Public ContactFeng Ji

The First Affiliated Hospital of Zhengzhou University

lichengdong114@163.com+86 15729361171

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 11, 2026